Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells.
Journal Information
Full Title: J Immunother Cancer
Abbreviation: J Immunother Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the computer code and data sets produced in this study are available in the following databases: the source code for compound screening is available at github ( https://github com/tiantz17/cmapfordc )."
"the computer code and data sets produced in this study are available in the following databases: the source code for compound screening is available at github ( https://github com/tiantz17/cmapfordc )."
"Competing interests: None declared."
"Funding: This study was supported by the National Key Research and Development Program of China (2020YFA0509400), National Natural Science Foundation of China (82073161, 32270982, 82241234), National Youth Talent Support Program, Tsinghua University Initiative Scientific Research Program, and Tsinghua-Peking University Center for Life Sciences (045-61020100119) to HT; National Natural Science Foundation of China (61872216, T2125007), the National Key Research and Development Program of China (2021YFF1201300), the Turing AI Institute of Nanjing, and the Tsinghua-Toyota Joint Research Fund to JZe; Health and Medical Research Fund of the Research Fund Secretariat, Food and Health Bureau, HKSAR, grant number 08193116."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025